GENOMADIX CUBE
LIVE

Serial Number

97978739

Owner

GENOMADIX INC.

Attorney

Sara M. Bauer

First Use Date

Sep 30, 2021

Filing Date

Nov 18, 2021

Add to watchlist:

No watchlists yet
View on USPTO

GENOMADIX CUBE Trademark

Serial Number: 97978739 • Registration: 7980198

GENOMADIX CUBE is a trademark filed by GENOMADIX INC. on November 18, 2021. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

GENOMADIX INC. (13 trademarks)

340 LEGGETT DRIVE
KANATA, ONTARIO K2K 2A4 , CA

Entity Type: 99

Trademark Details

Filing Date

November 18, 2021

Registration Date

October 14, 2025

First Use Anywhere

September 30, 2021

First Use in Commerce

July 31, 2023

Published for Opposition

August 26, 2025

Goods & Services

Biomedical diagnostic apparatus, namely, food and water safety tests for environmental monitoring; biomedical diagnostic apparatus, namely, molecular diagnostic device used for nucleic acid testing, infectious disease testing, genetic testing, and drug response testing for environmental monitoring for research purposes; biomedical devices in the nature of cartridges for loading biological samples for use in molecular diagnostic devices other than for medical use; testing sample collection equipment, namely, swabs for obtaining biological samples from subjects for research purposes

Clinical diagnostic reagents for medical use; diagnostic biomarker reagents for medical purposes; diagnostic reagents for clinical medical laboratory use; diagnostic reagents for medical diagnostic use; diagnostic reagents for medical laboratory use; medical diagnostic reagents; medical diagnostic reagents and assays for testing of body fluid; reagents for use in medical genetic testing; swabs for medical purposes

Diagnostic reagents for medical and scientific research purposes, not for medical use

Biomedical diagnostic apparatus, namely, molecular diagnostic device used for nucleic acid testing, infectious disease testing, genetic testing, and drug response testing for medical monitoring purposes; biomedical diagnostic devices in the nature of cartridges for loading biological samples for use in molecular diagnostic devices for medical purposes; medical devices for obtaining body fluid samples in the nature of testing sample collection equipment comprised of swabs for obtaining biological samples from subjects for biomedical purposes

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Oct 14, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Oct 14, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 26, 2025 NPUB
PUBLISHED FOR OPPOSITION
Aug 26, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 20, 2025 NONP
WITHDRAWN FROM PUB - OG REVIEW QUERY
Jul 22, 2025 PBCR
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 25, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 24, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 24, 2025 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Jun 24, 2025 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Mar 26, 2025 GNFN
FINAL REFUSAL E-MAILED
Mar 26, 2025 GNFR
FINAL REFUSAL WRITTEN
Mar 26, 2025 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 25, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 25, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 25, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 4, 2025 GNRN
NON-FINAL ACTION E-MAILED
Mar 4, 2025 GNRT
NON-FINAL ACTION WRITTEN
Mar 4, 2025 CNRT
USE AMENDMENT ACCEPTED
Mar 4, 2025 IUAA
AMENDMENT TO USE PROCESSING COMPLETE
Feb 13, 2025 AUPC
DIVISIONAL PROCESSING COMPLETE
Aug 28, 2024 DPCC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Aug 12, 2024 AITU
AMENDMENT TO USE PROCESSING COMPLETE
Jun 17, 2024 AUPC
USE AMENDMENT FILED
Jun 17, 2024 IUAF
DIVISIONAL REQUEST RECEIVED
Jun 17, 2024 DRRR
TEAS AMENDMENT OF USE RECEIVED
Jun 17, 2024 EAAU
TEAS REQUEST TO DIVIDE RECEIVED
Jun 17, 2024 ERTD
TEAS/EMAIL CORRESPONDENCE ENTERED
May 31, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 31, 2024 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
May 30, 2024 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Mar 20, 2024 GNS2
INQUIRY TO SUSPENSION E-MAILED
Mar 20, 2024 GNSI
SUSPENSION INQUIRY WRITTEN
Mar 20, 2024 CNSI
ASSIGNED TO EXAMINER
Mar 20, 2024 DOCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Feb 26, 2024 RCCK
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 7, 2023 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 7, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 7, 2023 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Dec 7, 2023 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Dec 7, 2023 COAR
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Aug 24, 2023 GNS3
LETTER OF SUSPENSION E-MAILED
Aug 24, 2023 GNSL
SUSPENSION LETTER WRITTEN
Aug 24, 2023 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 16, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 16, 2023 CRFA
ASSIGNED TO LIE
Aug 16, 2023 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Apr 5, 2023 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Apr 3, 2023 GNS2
INQUIRY TO SUSPENSION E-MAILED
Apr 3, 2023 GNSI
SUSPENSION INQUIRY WRITTEN
Apr 3, 2023 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Mar 30, 2023 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Aug 27, 2022 GNS3
LETTER OF SUSPENSION E-MAILED
Aug 27, 2022 GNSL
SUSPENSION LETTER WRITTEN
Aug 27, 2022 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 17, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 16, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 16, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 22, 2022 GNRN
NON-FINAL ACTION E-MAILED
Jul 22, 2022 GNRT
NON-FINAL ACTION WRITTEN
Jul 22, 2022 CNRT
ASSIGNED TO EXAMINER
Jul 19, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 23, 2021 NWOS
NEW APPLICATION ENTERED
Nov 22, 2021 NWAP